Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses
Open Access
- 28 July 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12, 707287
Abstract
Background: The outbreak of Coronavirus disease 2019 (COVID-19) has become an international public health crisis, and the number of cases with dengue co-infection has raised concerns. Unfortunately, treatment options are currently limited or even unavailable. Thus, the aim of our study was to explore the underlying mechanisms and identify potential therapeutic targets for co-infection. Methods: To further understand the mechanisms underlying co-infection, we used a series of bioinformatics analyses to build host factor interaction networks and elucidate biological process and molecular function categories, pathway activity, tissue-specific enrichment, and potential therapeutic agents. Results: We explored the pathologic mechanisms of COVID-19 and dengue co-infection, including predisposing genes, significant pathways, biological functions, and possible drugs for intervention. In total, 460 shared host factors were collected; among them, CCL4 and AhR targets were important. To further analyze biological functions, we created a protein-protein interaction (PPI) network and performed Molecular Complex Detection (MCODE) analysis. In addition, common signaling pathways were acquired, and the toll-like receptor and NOD-like receptor signaling pathways exerted a significant effect on the interaction. Upregulated genes were identified based on the activity score of dysregulated genes, such as IL-1, Hippo, and TNF-α. We also conducted tissue-specific enrichment analysis and found ICAM-1 and CCL2 to be highly expressed in the lung. Finally, candidate drugs were screened, including resveratrol, genistein, and dexamethasone. Conclusions: This study probes host factor interaction networks for COVID-19 and dengue and provides potential drugs for clinical practice. Although the findings need to be verified, they contribute to the treatment of co-infection and the management of respiratory disease.Keywords
This publication has 77 references indexed in Scilit:
- Transcriptomic Profiling of Diverse Aedes aegypti Strains Reveals Increased Basal-level Immune Activation in Dengue Virus-refractory Populations and Identifies Novel Virus-vector Molecular InteractionsPLOS Neglected Tropical Diseases, 2013
- Temporal Dynamics of the Transcriptional Response to Dengue Virus Infection in Nicaraguan ChildrenPLOS Neglected Tropical Diseases, 2012
- RIG-I, MDA5 and TLR3 Synergistically Play an Important Role in Restriction of Dengue Virus InfectionPLOS Neglected Tropical Diseases, 2011
- Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2American Journal of Physiology-Heart and Circulatory Physiology, 2010
- Clinical Findings and Pro-Inflammatory Cytokines in Dengue Patients in Western India: A Facility-Based StudyPLOS ONE, 2010
- GeneCards Version 3: the human gene integratorDatabase: The Journal of Biological Databases and Curation, 2010
- Enhancement by Tumor Necrosis Factor Alpha of Dengue Virus-Induced Endothelial Cell Production of Reactive Nitrogen and Oxygen Species Is Key to Hemorrhage DevelopmentJournal of Virology, 2008
- Both Virus and Tumor Necrosis Factor Alpha Are Critical for Endothelium Damage in a Mouse Model of Dengue Virus-Induced HemorrhageJournal of Virology, 2007
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Pathophysiologic and Prognostic Role of Cytokines in Dengue Hemorrhagic FeverThe Journal of Infectious Diseases, 1998